TRIM16 and cardiac hypertrophy: In a chronic kidney disease‐related heart injury model, TRIM16 mediates the ubiquitination and degradation of RIP2, inhibits p38 phosphorylation, and alleviates myocardial hypertrophy and diastolic dysfunction [249].